Researcher biography

Dr Ligong Liu received BSc (organic chemistry) in 1990 from Nankai University, China, MSc (medicinal chemistry) in 1993 from Beijing Medical University (currently Peking University Health Science Center) with research thesis studying steroids, and PhD in 1997 from Central Queensland University, Australia, investigating protoberberine alkaloids - the active components in many folkloric medicines. Following postdoctoral research at Central Queensland University and the Australian National University (1997-2001), he spent seven years in Australian biotech industries (Alchemia Ltd and Progen Pharmaceuticals Ltd) specializing in carbohydrate and oligosaccharide based therapeutics. Since 2008, he has been a Senior Research Officer in Professor Fairlie’s group at the Institute for Molecular Bioscience, University of Queensland. His research interests are in chemical synthesis, medicinal chemistry, drug design and development, combinatorial chemistry, modulators of enzymes/growth factors/G protein-coupled receptors associated with inflammatory disorders and cancers, and modulators of T cell immunity